Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.
Meng FanXiaofan GuWanli ZhangXiong-Wen ZhangRuiqin ZhangQiaoyu FangYueping WangXiaodong GuoXiong-Wen ZhangXuan LiuPublished in: Journal of cachexia, sarcopenia and muscle (2022)
AI ameliorates cancer cachexia by decreasing the production of IL-6 and EVs of tumour cells. The decreasing effects of AI on EVs biogenesis are based on its inhibition on STAT3/PKM2/SNAP23 pathway.